AmEx shareholders reject proposal to study risks of 'gender-affirming care' for minors' health plans
Coveragetap to expand ▾Spectrum: Mostly Center🌍Other: 2 · US: 1
- American Express shareholders voted 99.57% against a proposal to examine the company's coverage for sex-reassignment drugs and surgeries for minors (per Washington Times).
- American Express reported record financial results for 2025, contributing to the shareholders' decision to back the board (per Yahoo Finance).
- The overwhelming rejection of the proposal indicates a lack of support among shareholders for increased scrutiny on health care policies related to gender-affirming treatments (per Yahoo Finance).
The proposal sought to evaluate the implications of the company's coverage for sex-reassignment drugs and surgeries for underage patients, a contentious issue that has garnered significant attention in recent years.
Tim Schwarzenberger, director of corporate engagement for Inspire Investing, noted that the outcome was expected given the company's strong financial performance, suggesting that shareholders may be more focused on profitability than on social responsibility.
The overwhelming rejection of the proposal reflects a broader trend in corporate governance where financial results often take precedence over social issues. As companies navigate the complexities of health care policies and public opinion, the decision by American Express shareholders underscores the challenges of balancing corporate responsibility with shareholder interests.
- American Express shareholders rejected a proposal to study gender-affirming care, indicating a prioritization of financial performance over social issues, which may affect future corporate governance (per Washington Times).
- The rejection of the proposal suggests that shareholders are less concerned about the implications of health care policies for minors, potentially impacting the company's public image and stakeholder relations (per Yahoo Finance).
- The decision reflects a broader corporate trend where financial results overshadow social responsibility, which could influence how other companies approach similar proposals in the future (per Washington Times).
- Whether American Express will face any shareholder backlash or public criticism following the rejection of the proposal.
- The potential for similar proposals to be introduced at other corporate annual meetings in 2026.
- Any changes in American Express's health care policies or public statements regarding gender-affirming care in response to shareholder sentiment.
Left- and right-leaning outlets are covering this story differently — in which facts to emphasize, which context to include, and how to frame causes and consequences.
1 specific area where coverage diverges — see below.
- Yahoo Finance emphasizes the record financial results as a key factor in the shareholder vote, while Washington Times focuses on the implications of the rejected proposal regarding gender-affirming care.